Clinical Trials Sponsored by ONY

Total 7007 results

Ono Pharmaceutical Co. Ltd
Bristol-Myers Squibb

Completed

Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer

Esophageal Cancer

United States, Germany, Denmark, Italy, Japan, Taiwan, Korea, Republic of, United Kingdom
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)

Renal Cell Carcinoma

United States, Canada, Italy, Finland
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors

Advanced Cancer

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Retrospective Study of the Effectiveness and Safety of Nivolumab in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients in Japan

Non-Small Cell Lung Cancer

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) (CheckMate 647)

Lymphoma

United States, Canada, Hong Kong, Italy, Japan, France, Israel, Germany, Hungary, Brazil, Czechia, Russian Federation, Singapore
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies (MDX1106-03)

Renal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate Cancer

United States
Bristol-Myers Squibb
Ono Pharma USA Inc

Completed

Phase I Biomarker Study (BMS-936558)

Renal Cell Carcinoma

United States, France, Spain
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan

Juvenile Idiopathic Arthritis

Japan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has Spread

Advanced Malignancies

Japan
University Hospital, Toulouse
Celgene; Onyx Therapeutics, Inc.

Unknown

Front-line Therapy With Carfilzomib, Lenalidomide, and Dexamethasone Induction (IFM-CRd)

Multiple Myeloma

France
M.D. Anderson Cancer Center
Onyx Therapeutics, Inc.

Terminated

A Phase II Study of Carfilzomib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma

United States
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd

Completed

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

Renal Cell Carcinoma

Japan
Amneal Pharmaceuticals, LLC
Phase One Solutions, Inc.

Completed

Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

Hypogonadotropic Hypogonadism | Primary Hypogonadism

United States
Ono Pharmaceutical Co. Ltd
Astellas Pharma Inc

Completed

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

Involutional Osteoporosis

Japan
Astellas Pharma Inc
Ono Pharma USA Inc

Completed

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

Bone Diseases | Osteoporosis | Osteoporosis, Postmenopausal

Japan
Lyckeby Starch AB
FinnMedi Oy; Oy Medfiles Ltd

Suspended

Food Challenge With Barley Starch as Active Comparator (BALA)

Allergy;Food | Allergy Wheat

Finland
Vetrea Terveys Oy

Unknown

Goal Attainment Evaluation of Multidisciplinary Telerehabilitation After Traumatic Brain Injury

Traumatic Brain Injury

Finland
ON Light Sciences

Completed

Evaluation of the Safety and Efficacy of the DeScribe™ Patch

Tattoos

United States
National Cancer Center, Japan
Ono Pharmaceutical Co. Ltd

Recruiting

Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume) (Perfume)

Pancreatic Cancer | Low-grade Glioma

Japan
Hamilton Health Sciences Corporation
One Fertility

Not yet recruiting

Supplementation for Male Subfertility (FertEnhancer)

Male Infertility

Canada
Memorial Sloan Kettering Cancer Center
Celgene; Onyx/Amgen

Active, not recruiting

High Dose Carfilzomib for Newly Diagnosed Myeloma

Multiple Myeloma

United States
Pega-One S.A.S.
ICON plc

Withdrawn

Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma (I-PACE)

Cutaneous Squamous Cell Carcinoma
University of Miami
Office of Naval Research (ONR)

Completed

Noise Exposure and Near-Infrared Light

Hearing Loss, Noise-Induced

United States
SCRI Development Innovations, LLC
Novartis; Onyx Therapeutics, Inc.

Completed

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Gilead Sciences
Ono Pharmaceutical Co. Ltd; Galapagos NV

Completed

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

Sjogren's Syndrome

United States, Spain, United Kingdom, Poland
Prof. Tony hayek MD

Completed

The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.

Diabetes | Atherosclerosis | Dyslipidemias

Israel
Rony Schaffel

Terminated

Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALLPhi)

Acute Lymphoblastic Leukemia | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Case Comprehensive Cancer Center
Bayer; Onyx Therapeutics, Inc.

Terminated

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

Carcinoma, Hepatocellular

United States
Clinical Life Sciences Ltd.
Kiantama Oy; Suomen Sokeri Oy

Completed

A Comparative Study of Effects of Berry and Grain Products on Postprandial Glycemic Response in Healthy Subjects

Healthy

Finland
M.D. Anderson Cancer Center
Celgene; Onyx Therapeutics, Inc.

Terminated

Phase I/II Carfilzomib Plus Lenalidomide and Rituximab in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma

United States
Pfizer
Ono Pharmaceutical Co. Ltd; Pierre Fabre Laboratories

Completed

A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations (ERBA)

Healthy

United States
Taipei City Hospital
The One Biopharmaceutical Co., Ltd.

Completed

Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors

Non-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver Injury

Taiwan
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd; Exelixis

Active, not recruiting

A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 9ER)

Renal Cell Carcinoma

United States, Japan, Brazil, Argentina, Australia, Chile, Czechia, Germany, Greece, Israel, Italy, Mexico, Poland, Romania, Russian Federation, Spain, Turkey, United Kingdom
Bristol-Myers Squibb
Medarex; Ono Pharma USA Inc

Completed

Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Malignant Melanoma

United States
Oregon Health and Science University
The ONE Foundation

Completed

Pregnancy-Related Low Back Pain and Complementary and Alternative Medicine (CAM) Treatment

Low Back Pain

United States
Kyowa Kirin Co., Ltd.
Ono Pharmaceutical Co. Ltd

Completed

Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors

Solid Tumor

Japan
Prof. Tony hayek MD

Unknown

The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.

Obesity | Diabetes Mellitus | Atherosclerosis | Metabolic Syndrome | Dyslipidemias
Prof. Tony hayek MD

Unknown

Serum Oxidative Status as a Potential Predictor of Coronary Artery Disease.

Coronary Artery Disease | Paraoxanase 1 | Thiobarbituric Acid Reactive Substances | Thiol Groups
Ono Pharmaceutical Co. Ltd
Kyorin Pharmaceutical Co.,Ltd

Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Overactive Bladder

Japan
Alzinova AB
CRST Oy

Recruiting

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Alzheimer Disease | Dementia Alzheimers | Dementia, Mild

Finland
Medicortex Finland Oy
Satasairaala

Completed

Biochemical Diagnostics of Mild Traumatic Brain Injury (TBI) and Concussion in Children and Adolescents

Brain Injuries, Traumatic

Finland
Medtentia International Ltd Oy

Completed

5-Year Follow-Up Safety and Performance Evaluation of the Medtentia Annuloplasty Ring in Adults

Mitral Regurgitation | Mitral Insufficiency

Finland
Avena Nordic Grain Oy

Completed

Evaluation of Safety and Tolerability of a Rapeseed Food Ingredient (RYPSI-ING)

Food Safety

Finland
Targovax Oy

Completed

ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

Malignant Solid Tumour

Finland
Calvary Hospital, Bronx, NY

Unknown

Detection of Osteomyelitis Using High Resolution Ultrasound

Chronic Osteomyelitis

United States
Emotional Brain NY Inc.

Completed

Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems

Hypoactive Sexual Desire Disorder

United States
Medtentia International Ltd Oy

Terminated

Study on Safety and Performance of Medtentia Mitral Valve Repair System in Surgical Repair of Mitral Regurgitation

Mitral Regurgitation | Mitral Insufficiency

Finland
Calvary Hospital, Bronx, NY

Suspended

Effect of Hyaluronic Acid ECM on Venous Ulcers

Venous Ulcers

United States
Oy Karl Fazer Ab

Completed

Effects of Wheat Breads on Symptoms of IBS, a Pilot Study (Wheat-IBS)

Irritable Bowel Syndrome | Wheat Sensitivity

Finland
Emotional Brain NY Inc.

Completed

Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder

Hypoactive Sexual Desire Disorder

United States

Clinical Trials Sponsored by ONY

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations